Insider Transactions in Q4 2024 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2024
|
Nadim Ahmed President and CEO |
SELL
Open market or private sale
|
Direct |
8,400
-3.09%
|
$92,400
$11.87 P/Share
|
|
Dec 18
2024
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,482
-3.7%
|
$38,302
$11.41 P/Share
|
|
Dec 18
2024
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,632
-3.9%
|
$50,952
$11.41 P/Share
|
|
Dec 18
2024
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,693
-4.49%
|
$51,623
$11.41 P/Share
|
|
Dec 12
2024
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,489
-3.23%
|
$41,868
$12.52 P/Share
|
|
Nov 05
2024
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-6.9%
|
$120,000
$15.64 P/Share
|